Is the Amyloid Hypothesis of Alzheimer's disease therapeutically relevant?
Year: 2012
Type: review
Abstract: The conventional view of AD (Alzheimer's disease) is that much of the pathology is driven by an increased load of β-amyloid in the brain of AD patients (the 'Amyloid Hypothesis'). Yet, many therapeutic strategies based on lowering β-amyloid have so far failed in clinical trials. This failure of β-amyloid-lowering agents has caused many to question the Amyloid Hypothesis itself. However, AD is likely to be a complex disease driven by multiple factors. In addition, it is increasingly clear that β-amyloid processing involves many enzymes and signalling pathways that play a role in a diverse array of cellular processes. Thus the clinical failure of β-amyloid-lowering agents does not mean that the hypothesis itself is incorrect; it may simply mean that manipulating β-amyloid directly is an unrealistic strategy for therapeutic intervention, given the complex role of β-amyloid in neuronal physiology. Another possible problem may be that toxic β-amyloid levels have already caused irreversible damage to downstream cellular pathways by the time dementia sets in. We argue in the present review that a more direct (and possibly simpler) approach to AD therapeutics is to rescue synaptic dysfunction directly, by focusing on the mechanisms by which elevated levels of β-amyloid disrupt synaptic physiology.
Source: Biochemical Journal
DOI: 10.1042/bj20120653
Authors: Andrew F. Teich, Ottavio Arancio
Institution: Columbia University Irving Medical Center
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Awards: Novel PDE5 inhibitors as a therapeutic tool against Alzheimer's Disease, Calpain Inhibitors against Alzheimer's Disease, Dysregulation of Histone Acetylation in Alzheimer Disease, Beta-Amyloid42 positively regulates Alpha7-Cholinergic Receptors, SUMOylation and Amyloid-beta elevation, Endogenous amyloid-beta in synaptic function and memory
OpenAlex ID: W2146670116
